Versiti Executive and Leadership Team

Christopher Miskel, the President & Chief Executive Officer at Versiti, directs the overarching strategic vision for national blood health initiatives. Miskel architects long-term growth plans that prioritize transfusion medicine and transplantation services. By aligning organizational goals with the needs of healthcare partners, the President & Chief Executive Officer ensures consistent delivery of value-added solutions. This leadership role involves constant engagement with the Board to maintain high standards in patient care and operational excellence. Christopher Miskel monitors market trends to identify opportunities for expanding access to care across the United States. Through rigorous oversight of corporate performance, the President & Chief Executive Officer drives the mission of improving patient outcomes. Miskel fosters a culture of innovation that supports the complex requirements of blood-related disease management. Ultimately, the President & Chief Executive Officer secures the financial and clinical stability of the entire organization.

Byron Buhner, the President & Chief Executive Officer at Versiti, manages the integration of clinical research with practical healthcare delivery systems. Buhner focuses on scaling transfusion medicine capabilities to meet the evolving demands of national healthcare partners. The President & Chief Executive Officer coordinates cross-functional teams to optimize the supply chain for blood-related products. By streamlining internal processes, Byron Buhner enhances the efficiency of transplantation services provided to patients. This executive role requires deep collaboration with medical directors to ensure compliance with safety standards. Buhner evaluates the impact of new diagnostic technologies on overall patient health. Through the implementation of data-driven strategies, the President & Chief Executive Officer improves the accessibility of critical medical resources. Buhner maintains a focus on sustainable growth while addressing the unique challenges of blood health. The President & Chief Executive Officer consistently delivers results that strengthen the market position of the organization.

Dennis Mestrich, the President & Chief Executive Officer at Versiti, oversees the expansion of regional partnerships to bolster national blood health infrastructure. Mestrich directs the development of specialized programs for blood-related diseases, ensuring that healthcare systems receive high-quality support. The President & Chief Executive Officer evaluates the effectiveness of current service models to maximize cost efficiencies for partners. Dennis Mestrich leads initiatives that bridge the gap between laboratory innovation and bedside patient care. This leadership position involves managing complex stakeholder relationships to ensure alignment with the core mission. Mestrich drives the adoption of best practices in transfusion medicine across all operational units. By analyzing performance metrics, the President & Chief Executive Officer identifies areas for continuous improvement in service delivery. Mestrich champions the advancement of transplantation medicine to improve long-term patient outcomes. The President & Chief Executive Officer maintains a clear focus on achieving operational excellence throughout the entire organization.

Terri Ainsworth, the Chief Financial Officer at Versiti, manages the fiscal health and resource allocation for all national blood health programs. Ainsworth directs the budgeting process to ensure that capital investments align with the strategic goals of transfusion medicine and transplantation services. The Chief Financial Officer monitors revenue streams and cost structures to maintain the financial viability of the organization. Terri Ainsworth provides critical financial insights to the Board, enabling informed decision-making regarding future growth. This role involves overseeing financial reporting and compliance to ensure transparency across all departments. Ainsworth implements strategies that drive cost efficiencies for healthcare partners, directly supporting the mission of expanded access to care. By managing financial risks, the Chief Financial Officer protects the long-term stability of the company. Ainsworth evaluates the economic impact of new medical technologies on the overall business model. The Chief Financial Officer ensures that financial resources support the delivery of superior patient outcomes.

Sarah Kenyon, the Executive Assistant To Chief Financial Officer and Chief Human Resources Officer at Versiti, coordinates the administrative operations for the finance and human resources departments. Kenyon facilitates communication between these key functions to ensure organizational alignment with the mission of blood health innovation. The Executive Assistant To Chief Financial Officer and Chief Human Resources Officer manages complex scheduling and project tracking for senior leadership. Sarah Kenyon supports the execution of strategic initiatives by organizing essential documentation and meeting agendas. This role involves maintaining high standards of efficiency in daily operations to support the broader goals of the company. Kenyon assists in the preparation of reports that track financial performance and human capital development. By streamlining administrative tasks, the Executive Assistant To Chief Financial Officer and Chief Human Resources Officer allows leadership to focus on critical business outcomes. Kenyon ensures that all departmental activities remain synchronized with the overall corporate strategy.

Derek Tyus, the Executive Vice President & Chief Financial Officer at Versiti, oversees the long-term financial planning and investment strategies for the organization. Tyus directs the analysis of market trends to ensure that capital is deployed effectively across transfusion medicine and transplantation divisions. The Executive Vice President & Chief Financial Officer manages the financial health of the company by optimizing revenue cycles and controlling operational expenses. Derek Tyus collaborates with the leadership team to develop financial models that support the mission of improving patient care. This role involves monitoring the economic landscape to identify potential risks and opportunities for the business. Tyus ensures that financial operations remain compliant with industry regulations while supporting the growth of the company. By providing strategic financial guidance, the Executive Vice President & Chief Financial Officer enables the organization to achieve its goals for cost efficiency. Tyus maintains a focus on sustainable financial performance to support the delivery of high-quality healthcare services.

Brian Bautista, the Executive Vice President & Chief Operating Officer at Versiti, manages the daily operational activities across all national blood health facilities. Bautista directs the logistics of transfusion medicine and transplantation services to ensure timely delivery to healthcare partners. The Executive Vice President & Chief Operating Officer oversees the implementation of quality control measures that maintain the highest standards of patient safety. Brian Bautista coordinates the efforts of regional teams to optimize the efficiency of blood-related disease management. This role involves working closely with the C-suite to align operational capabilities with the strategic mission of the company. Bautista monitors performance metrics to identify bottlenecks and implement solutions that improve service delivery. By streamlining internal processes, the Executive Vice President & Chief Operating Officer enhances the overall productivity of the organization. Bautista ensures that operational resources are utilized effectively to support the growth of the business. The Executive Vice President & Chief Operating Officer drives the execution of operational excellence across the entire company.

Rodeina Davis, the Chief Information Officer at Versiti, architects the digital infrastructure necessary to support national blood health operations. Davis manages the implementation of secure data systems that facilitate seamless communication between healthcare partners and clinical teams. The Chief Information Officer drives the adoption of advanced analytics to improve the accuracy of transfusion medicine diagnostics. Rodeina Davis oversees the protection of sensitive patient information through robust cybersecurity protocols. This role involves collaborating with other C-suite leaders to integrate technology into every aspect of the business model. Davis optimizes internal workflows by deploying scalable software solutions that enhance operational efficiency. By modernizing the digital landscape, the Chief Information Officer ensures that the organization remains at the forefront of medical innovation. Davis monitors emerging technologies to identify potential improvements for transplantation services. The Chief Information Officer provides the technical foundation required to deliver high-quality care to patients nationwide.

Chrissy Schroeder, the Executive Vice President & Chief Marketing Officer at Versiti, directs the brand strategy and market positioning for all blood health services. Schroeder architects campaigns that communicate the value of transfusion medicine and transplantation solutions to healthcare partners nationwide. The Executive Vice President & Chief Marketing Officer manages outreach efforts to expand the reach of the organization in key markets. Chrissy Schroeder analyzes market data to identify opportunities for growth and service differentiation. This role involves collaborating with clinical teams to ensure that marketing messages accurately reflect the impact of the company on patient outcomes. Schroeder oversees the development of educational materials that support the mission of improving blood health. By building strong relationships with stakeholders, the Executive Vice President & Chief Marketing Officer enhances the reputation of the organization. Schroeder drives the adoption of innovative marketing tools to reach a broader audience. The Executive Vice President & Chief Marketing Officer ensures that the brand remains a leader in the health services industry.

Lynne Briggs, the Vice President & Chief Information Officer at Versiti, leads the development of digital platforms that support the clinical and administrative needs of the organization. Briggs directs the integration of new software systems that enhance the efficiency of transfusion medicine and transplantation services. The Vice President & Chief Information Officer manages the data architecture required to track patient outcomes and improve care delivery. Lynne Briggs oversees the implementation of advanced technology solutions that streamline communication between healthcare partners. This role involves collaborating with other executives to ensure that digital tools support the overall business strategy. Briggs monitors the performance of information systems to ensure reliability and security across all operations. By leveraging data analytics, the Vice President & Chief Information Officer provides insights that drive improvements in blood health services. Briggs maintains a focus on innovation to keep the organization at the forefront of the health services industry. The Vice President & Chief Information Officer ensures that technology remains a key driver of success.